The Cost of Obsessive-compulsive Disorder (OCD) in China (OCD)

November 13, 2020 updated by: Zhen Wang, Shanghai Mental Health Center

The Cost of Obsessive-compulsive Disorder (OCD) in China: Multi-center Cross-sectional Survey Based on Hospital

The purpose of this study is to estimate the cost of obsessive-compulsive disorder in China based on the prevalence rate from a social perspective.

Study Overview

Status

Withdrawn

Intervention / Treatment

Detailed Description

Obsessive-compulsive disorder(OCD) is one of relatively common mental disorders with a prevalence of 1.63% in China. OCD usually begins in adolescence or young adulthood , it will become a chronic disabling disease, if it is not treated in timeand.OCD can be so severe that it can seriously impact on some or all areas of a person's life, bring huge economic burden. At present, there is only one article on the cost of OCD in the United States in the 1990s, and this part of the data in China is blank.A cross-sectional study recruited 600 patients with OCD from 13 hospitals in eastern, western, southern, and northern China. A structured questionnaire was used for face-to-face interviewing to collect costs related to OCD. The direct costs for each patient and indirect costs ffor each patient and their caregivers were calculated . The human capital method is used to calculate indirect costs. Through weighting, the cost of OCD in China is estimated from a social perspective using a bottom-up methodology.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200030
        • Shanghai Mental Health Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 65 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients with obsessive-compulsive disorder are recruited from both outpatient clinics and inpatient departments

Description

Inclusion Criteria:

  • primarily diagnosed OCD meet DSM-5 critera
  • 16-65 years old
  • Get informed consent from patients

Exclusion Criteria:

  • Concurrent neuropsychiatric diseases such as schizophrenia, which severely interfere with treatment costs
  • Drug abuser
  • Unable to understand the questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Participants
OCD patients come from 13 hospitals located in the north, south, east and west of China
cross sectional study,no intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
obsessive-compulsive disorder related costs in China
Time Frame: 1 year
Estimating the direct and indirect Costs of Chinese OCD based on prevalence from a social perspective
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Direct costs and indirect costs of consumed resources
Time Frame: 1 year
Direct costs include medical costs and transportation, food, accommodation, etc. corresponding related to clinics.Indirect costs include lost time for patients and family members due to OCD.
1 year
other costs directly associated with OCD
Time Frame: 1 year
Other medical costs and economic loss of disruptive behaviors due to OCD
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 2, 2020

Primary Completion (Anticipated)

October 1, 2020

Study Completion (Anticipated)

October 1, 2020

Study Registration Dates

First Submitted

December 30, 2019

First Submitted That Met QC Criteria

December 30, 2019

First Posted (Actual)

January 2, 2020

Study Record Updates

Last Update Posted (Actual)

November 17, 2020

Last Update Submitted That Met QC Criteria

November 13, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obsessive-Compulsive Disorder

Clinical Trials on No intervention

3
Subscribe